Coloplast Dividends and Buybacks
Dividend criteria checks 3/6
Coloplast is a dividend paying company with a current yield of 3.46%.
Key information
3.5%
Dividend yield
-0.2%
Buyback Yield
| Total Shareholder Yield | 3.3% |
| Future Dividend Yield | 3.8% |
| Dividend Growth | 11.5% |
| Next dividend pay date | n/a |
| Ex dividend date | n/a |
| Dividend per share | n/a |
| Payout ratio | 109% |
Recent dividend and buyback updates
Coloplast's (CPH:COLO B) Upcoming Dividend Will Be Larger Than Last Year's
Dec 04
Coloplast's (CPH:COLO B) Upcoming Dividend Will Be Larger Than Last Year's
Nov 13Recent updates
Investors Still Waiting For A Pull Back In Coloplast A/S (CPH:COLO B)
May 25Does Coloplast (CPH:COLO B) Have A Healthy Balance Sheet?
May 06Are Investors Undervaluing Coloplast A/S (CPH:COLO B) By 35%?
Apr 18Coloplast A/S' (CPH:COLO B) Share Price Could Signal Some Risk
Jan 27An Intrinsic Calculation For Coloplast A/S (CPH:COLO B) Suggests It's 47% Undervalued
Jan 09Coloplast's (CPH:COLO B) Upcoming Dividend Will Be Larger Than Last Year's
Dec 04Should Shareholders Have Second Thoughts About A Pay Rise For Coloplast A/S' (CPH:COLO B) CEO This Year?
Nov 29Coloplast's (CPH:COLO B) Upcoming Dividend Will Be Larger Than Last Year's
Nov 13Earnings Update: Coloplast A/S (CPH:COLO B) Just Reported Its Annual Results And Analysts Are Updating Their Forecasts
Nov 08
Operational Efficiencies And Innovations In Urology And Wound Care Propel Future Growth
Improved operational efficiency and strategic expansions are expected to enhance net margins and earnings over the long term.Coloplast (CPH:COLO B) Seems To Use Debt Quite Sensibly
Oct 18Coloplast A/S Earnings Missed Analyst Estimates: Here's What Analysts Are Forecasting Now
Aug 23Are Investors Undervaluing Coloplast A/S (CPH:COLO B) By 38%?
Aug 22Subdued Growth No Barrier To Coloplast A/S' (CPH:COLO B) Price
Jul 17These 4 Measures Indicate That Coloplast (CPH:COLO B) Is Using Debt Reasonably Well
Jun 29Stability and Growth of Payments
Fetching dividends data
Stable Dividend: COLO B's dividends per share have been stable in the past 10 years.
Growing Dividend: COLO B's dividend payments have increased over the past 10 years.
Dividend Yield vs Market
| Coloplast Dividend Yield vs Market |
|---|
| Segment | Dividend Yield |
|---|---|
| Company (COLO B) | 3.5% |
| Market Bottom 25% (DK) | 1.5% |
| Market Top 25% (DK) | 4.7% |
| Industry Average (Medical Equipment) | 1.7% |
| Analyst forecast (COLO B) (up to 3 years) | 3.8% |
Notable Dividend: COLO B's dividend (3.46%) is higher than the bottom 25% of dividend payers in the Danish market (1.48%).
High Dividend: COLO B's dividend (3.46%) is low compared to the top 25% of dividend payers in the Danish market (4.73%).
Earnings Payout to Shareholders
Earnings Coverage: With its high payout ratio (109.1%), COLO B's dividend payments are not well covered by earnings.
Cash Payout to Shareholders
Cash Flow Coverage: With its high cash payout ratio (101.7%), COLO B's dividend payments are not well covered by cash flows.
Discover strong dividend paying companies
Company Analysis and Financial Data Status
| Data | Last Updated (UTC time) |
|---|---|
| Company Analysis | 2025/05/31 18:06 |
| End of Day Share Price | 2025/05/28 00:00 |
| Earnings | 2025/03/31 |
| Annual Earnings | 2024/09/30 |
Data Sources
The data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.
| Package | Data | Timeframe | Example US Source * |
|---|---|---|---|
| Company Financials | 10 years |
| |
| Analyst Consensus Estimates | +3 years |
|
|
| Market Prices | 30 years |
| |
| Ownership | 10 years |
| |
| Management | 10 years |
| |
| Key Developments | 10 years |
|
* Example for US securities, for non-US equivalent regulatory forms and sources are used.
Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more.
Analysis Model and Snowflake
Details of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.
Learn about the world class team who designed and built the Simply Wall St analysis model.
Industry and Sector Metrics
Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on Github.
Analyst Sources
Coloplast A/S is covered by 49 analysts. 20 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.
| Analyst | Institution |
|---|---|
| null null | ABG Sundal Collier |
| Robert Bate | Barclays |
| Hassan Al-Wakeel | Barclays |